MedTrace Logo

Effects of TRF on Obese Patients With CKD Stage 3-4

NCT05037747 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-07-07

No results posted yet for this study

Summary

Obesity is associated with glomerular hyperfiltration leading to renal impairment and is a risk factor for the progression of kidney disease.Weight loss can reduce proteinuria and improve eGFR.Intermittent fasting is safe and effective, and in addition to improving body shape and weight in obese patients, it can also improve glucolipid metabolism, reduce proteinuria, improve kidney function and delay the progression of kidney disease.

Conditions

  • Time Restricted Feeding
  • Renal Insufficiency, Chronic
  • Obesity

Interventions

BEHAVIORAL

Time-restricted feeding(TRF)

The TRF group was asked to restrict the eating window to 8 hours a day, during waking hours and also continue a low-protein diet.

Sponsors & Collaborators

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Xu-sheng Liu, M.M · Guangdong Provincial Hospital of Traditional Chinese Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-12
Primary Completion
2022-03-30
Completion
2022-07-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05037747 on ClinicalTrials.gov